Accenture director granted 9 dividend RSU shares

Uotani Masahiko reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Uotani Masahiko reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc director Masahiko Uotani reported an award of 9 Class A ordinary shares on August 14, 2026. The award represents Restricted Share Units (RSUs) granted under anti-dilution provisions to reflect Accenture's payment of a cash dividend. Following this grant, Uotani holds 1,258 Class A shares directly.

Insider Trade Summary

Grant/Award: 9 shares

Grant/Award 1 txn

Insider Uotani Masahiko

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares F1	9	$0.00	$0.00

Holdings After Transaction: Class A ordinary shares — 1,258 shares (Direct)

Footnotes (1)

1. F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Key Figures

RSU-related shares granted: 9 shares Stated price per share: $0.0000 Shares owned after transaction: 1,258 shares

3 metrics

RSU-related shares granted 9 shares Grant of Class A ordinary shares via RSU anti-dilution adjustment on August 14, 2026

Stated price per share $0.0000 Per-share value for the 9 granted Class A ordinary shares

Shares owned after transaction 1,258 shares Total direct Class A shareholdings for Masahiko Uotani following the August 14, 2026 grant

Key Terms

Restricted Share Units (RSUs), anti-dilution provisions, cash dividend

3 terms

Restricted Share Units (RSUs) financial

"Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

anti-dilution provisions financial

"pursuant to the anti-dilution provisions of previously granted RSU awards"

Anti-dilution provisions are contract terms that protect an investor’s percentage ownership when a company issues new shares at a lower price than the investor originally paid. They work like an automatic recalculation of split pieces when a pie gets cut into more slices, preserving the investor’s relative stake and reducing unexpected losses of ownership and voting power, which matters because it affects potential control, future returns, and valuation of an investment.

cash dividend financial

"to reflect Accenture plc's payment of a cash dividend"

A cash dividend is a payment made by a company to its shareholders directly in money, usually on a regular schedule. It is a way for investors to receive a portion of the company's profits, similar to earning interest or a bonus for holding the company's stock. Cash dividends provide income to shareholders and can indicate the company's financial health and stability.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ACN director Masahiko Uotani report on this Form 4?

Masahiko Uotani reported an award of 9 Class A ordinary shares of Accenture plc on August 14, 2026. The shares were received as a grant, not a market purchase, and relate to previously granted RSU awards.

Why did Masahiko Uotani receive additional RSUs in Accenture (ACN)?

The 9 RSUs were granted under anti-dilution provisions tied to earlier RSU awards. They were issued to reflect Accenture plc's payment of a cash dividend, maintaining the economic value of the prior equity awards.

What is Masahiko Uotani’s total direct Accenture (ACN) shareholding after this transaction?

After the transaction, Masahiko Uotani directly holds 1,258 Class A ordinary shares of Accenture plc. This figure reflects his position immediately following the 9-share RSU-related grant reported on this Form 4.

Did Masahiko Uotani buy or sell Accenture (ACN) shares in the market?

No market buy or sell occurred; the Form 4 reports an acquisition via grant of 9 shares at a stated price of $0.00 per share. This reflects an RSU-related adjustment, not an open-market trade.

Is the reported Accenture (ACN) RSU grant related to a Rule 10b5-1 trading plan?

The filing’s 10b5-1 checkbox is unchecked, and no footnote references a trading plan. The transaction is described instead as a grant of RSUs under anti-dilution provisions tied to a cash dividend.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 04:47 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Uotani Masahiko

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	08/14/2026		A		9(1)	A	$0	1,258	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Allyson Retson, Attorney-in-Fact for Masahiko Uotani	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)